Glucokinase activators as new type 2 diabetes therapeutic agents

Author： Sarabu Ramakanth Berthel Steven J Kester Robert F Tilley Jefferson W

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.7, 2008-07, pp. : 759-768

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucokinase Activators for the Potential Treatment of Type 2 Diabetes

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 17, 2008-11 ,pp. : 1524-1532

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes

By Pfefferkorn Jeffrey A

Expert Opinion on Drug Discovery, Vol. 8, Iss. 3, 2013-03 ,pp. : 319-330

Informa Healthcare

Access to resources Recommend Favorite

Recent Updates on Glucokinase Activators for the Treatment of Type 2 Diabetes Mellitus

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-06 ,pp. : 585-602

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy

Current Medicinal Chemistry, Vol. 13, Iss. 15, 2006-06 ,pp. : 1839-1843

Bentham Science Publishers

Access to resources Recommend Favorite

Glucokinase activators in diabetes management

By Coghlan Matthew Leighton Brendan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 145-167

Informa Healthcare

Access to resources Recommend Favorite